NextGen Immuno Therapeutics
NextGen Immuno Therapeutics develops AI-driven diagnostics and therapies for immune-related diseases. It leverages multimodal data and precision medicine to identify targets and tailor treatments. As a biotechnology company, it provides diagnostic tools and therapeutic options for conditions such as GVHD, transplant rejection, autoimmune disorders, cancer immunotherapy, and infectious diseases. Its platform-oriented approach targets research institutions, healthcare providers, and pharma partners, with growing potential to scale through collaborations.
NextGen Immuno Therapeutics
NextGen Immuno Therapeutics develops AI-driven diagnostics and therapies for immune-related diseases. It leverages multimodal data and precision medicine to identify targets and tailor treatments. As a biotechnology company, it provides diagnostic tools and therapeutic options for conditions such as GVHD, transplant rejection, autoimmune disorders, cancer immunotherapy, and infectious diseases. Its platform-oriented approach targets research institutions, healthcare providers, and pharma partners, with growing potential to scale through collaborations.